Published Guidance, NICE advice and quality standards

Skip to filters Skip to results

Showing 11 to 11 of 11

Sort by

Last updated date between 1/3/2018 and 31/3/2018Remove Last updated date between 1/3/2018 and 31/3/2018 filter
Type: GuidanceRemove Type: Guidance filter
Type: Quality standardRemove Type: Quality standard filter
Guidance programme: Technology appraisal guidanceRemove Guidance programme: Technology appraisal guidance filter
Guidance programme: Interventional procedures guidanceRemove Guidance programme: Interventional procedures guidance filter
Guidance programme: Clinical guidelinesRemove Guidance programme: Clinical guidelines filter
Guidance programme: Social care guidelinesRemove Guidance programme: Social care guidelines filter
Guidance programme: Antimicrobial prescribing guidelinesRemove Guidance programme: Antimicrobial prescribing guidelines filter
Guidance programme: Cancer service guidelinesRemove Guidance programme: Cancer service guidelines filter
Guidance programme: Diagnostics guidanceRemove Guidance programme: Diagnostics guidance filter
Guidance programme: Highly specialised technologies guidanceRemove Guidance programme: Highly specialised technologies guidance filter
Guidance programme: Medical technologies guidanceRemove Guidance programme: Medical technologies guidance filter
Guidance programme: Medicines practice guidelinesRemove Guidance programme: Medicines practice guidelines filter
Guidance programme: Safe staffing guidelinesRemove Guidance programme: Safe staffing guidelines filter

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Pertuzumab with trastuzumab and docetaxel for treating HER2-positive breast cancer	TA509	7 March 2018	7 March 2018

Results per page

10
25
50
All